DSM-Firmenich AG

Growth is a weak point here. Earnings are outgrowing revenue, a sign of improving margins and operating leverage. Quality of growth is high even if the top line is moderate. The one thing to watch: the company is not profitable yet.

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case. The strongest point: it's up 62% over the past year, now sitting right at its 52-week high.

Valuation is a weak point here. Neither multiples nor yields stand out strongly. Value investors may want to wait for a better entry or look elsewhere. The strongest point: its forward P/E of 29x is 54% below that median, and its three-year P/E of 23x is 63% below. The one thing to watch: the earnings multiple is high.

Business quality is a weak point here. Debt is high relative to earnings and overall quality is below the market. Balance-sheet risk is the main watch-item. The one thing to watch: the net margin is negative.